Patents by Inventor Keisuke Fukuchi

Keisuke Fukuchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11870245
    Abstract: A surge suppression device includes a plurality of series circuits each of which is composed of a resistor and a capacitor, a case in which a plurality of the resistors and a plurality of the capacitors are placed, wherein respective ends of the plurality of series circuits on the capacitor side are electrically connected to each other via a connection electrode provided on the case. A motor wiring component includes a plurality of conductive wires connected to stator coils of the motor, wiring terminals that are provided at ends of the plurality of conductive wires on a side opposite to the side connected to the stator coils and are connected to electrodes of a terminal block, and the surge suppression device.
    Type: Grant
    Filed: February 22, 2022
    Date of Patent: January 9, 2024
    Assignee: PROTERIAL, LTD.
    Inventor: Keisuke Fukuchi
  • Publication number: 20230340118
    Abstract: An object of the present invention is to provide a novel anti-CD147 antibody exhibiting potent antitumor efficacy and having excellent safety. Another object of the present invention is to provide a pharmaceutical product comprising such an antibody. Another object of the present invention is to provide a method for treating tumors using the antibody or the pharmaceutical product, for example. The present invention provides a CD147-specific antibody that activates CD147 and exhibits high antitumor efficacy. The present invention provides the anti-CD147 antibody that exhibits high antitumor efficacy independent of effector functions. The present invention provides a pharmaceutical composition comprising such an anti-CD147 antibody. The present invention provides a method for treating tumors using such an anti-CD147 antibody and/or pharmaceutical composition.
    Type: Application
    Filed: May 10, 2023
    Publication date: October 26, 2023
    Applicant: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Keisuke FUKUCHI, Kayoko NANAI, Masato AMANO, Kozo YONEDA, Yusuke TOTOKI, Shoji YAMAMOTO
  • Patent number: 11768114
    Abstract: A temperature sensor detects temperatures of at least two distribution lines and includes a temperature detection unit and a protection member that covers the temperature detection unit. The protection member is provided with a first abutting surface that has a concave shape corresponding to an outer shape of a first distribution line and is in contact with the first distribution line and a second abutting surface that has a concave shape corresponding to an outer shape of a second distribution line and is in contact with the second distribution line.
    Type: Grant
    Filed: October 22, 2020
    Date of Patent: September 26, 2023
    Assignees: Proterial, Ltd., Hitachi Astemo Electric Motor Systems, Ltd.
    Inventors: Keisuke Fukuchi, Masanori Sagawa, Masashi Yokoi
  • Publication number: 20230268104
    Abstract: A resistor includes a resistor main body, and a resin portion covering the resistor main body. The resin portion includes a radiation fin.
    Type: Application
    Filed: February 22, 2023
    Publication date: August 24, 2023
    Applicant: Proterial, Ltd.
    Inventor: Keisuke FUKUCHI
  • Publication number: 20230178272
    Abstract: A resistor is composed of a resistor body part and a molded resin in which the resistor body part is embedded. The molded resin includes a base resin and a filler that is higher in thermal conductivity than the base resin.
    Type: Application
    Filed: November 30, 2022
    Publication date: June 8, 2023
    Applicant: Hitachi Metals, Ltd.
    Inventor: Keisuke FUKUCHI
  • Patent number: 11661451
    Abstract: An object of the present invention is to provide a novel anti-CD147 antibody exhibiting potent antitumor efficacy and having excellent safety. Another object of the present invention is to provide a pharmaceutical product comprising such an antibody. Another object of the present invention is to provide a method for treating tumors using the antibody or the pharmaceutical product, for example. The present invention provides a CD147-specific antibody that activates CD147 and exhibits high antitumor efficacy. The present invention provides the anti-CD147 antibody that exhibits high antitumor efficacy independent of effector functions. The present invention provides a pharmaceutical composition comprising such an anti-CD147 antibody. The present invention provides a method for treating tumors using such an anti-CD147 antibody and/or pharmaceutical composition.
    Type: Grant
    Filed: July 26, 2018
    Date of Patent: May 30, 2023
    Assignee: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Keisuke Fukuchi, Kayoko Nanai, Masato Amano, Kozo Yoneda, Yusuke Totoki, Shoji Yamamoto
  • Patent number: 11652382
    Abstract: A motor wiring member configured to supply three-phase alternating current to a motor includes conductive wires, each of which has a connecting portion being provided at one end and being configured to be connected to a coil end of a stator of the motor, a terminal being provided at an other end of each conductive wire and being configured to be connected to an electrode of a terminal block, and a surge suppression section being configured to suppress an overvoltage from being applied to the motor. The surge suppression section includes three series circuits, each of which includes a resistor and a capacitor. One ends of the three series circuits are electrically connected to the conductive wires of respective phases, and other ends of the three series circuits are electrically connected to each other. The surge suppression section is provided along with the conductor wires near the terminal and is located between the terminal and the connecting portion.
    Type: Grant
    Filed: August 4, 2021
    Date of Patent: May 16, 2023
    Assignee: PROTERIAL, LTD.
    Inventors: Masanori Sagawa, Yuta Sugiyama, Keisuke Fukuchi, Yukio Ikeda
  • Publication number: 20230009239
    Abstract: A wiring component with physical quantity sensor is provided with an electric wire, a physical quantity sensor to detect a physical quantity of the electric wire, a holding member that is composed of a molded body covering a portion in a longitudinal direction of the electric wire and has a holding hole to house the physical quantity sensor, and an attachment member attached to the holding member. The physical quantity sensor is prevented from coming out of the holding hole by the attachment member.
    Type: Application
    Filed: July 1, 2022
    Publication date: January 12, 2023
    Inventor: Keisuke FUKUCHI
  • Publication number: 20220319738
    Abstract: A wiring component with physical quantity sensor is provided with a plurality of electric wires, a physical quantity sensor for detecting a physical quantity of the plurality of electric wires, an electric wire holding member including an intervening portion interposed between the plurality of electric wires, and a holder holding the physical quantity sensor. The electric wire holding member includes a protrusion protruding from the intervening portion in a direction perpendicular to an arrangement direction of the plurality of electric wires, and aligning the holder in longitudinal directions of the plurality of electric wires by the protrusion. The holder includes an electric wire engaging portion being engaged with at least one of the plurality of electric wires.
    Type: Application
    Filed: March 28, 2022
    Publication date: October 6, 2022
    Inventor: Keisuke FUKUCHI
  • Patent number: 11459387
    Abstract: An object of the present invention is to provide a novel anti-CD147 antibody exhibiting potent antitumor efficacy and having excellent safety. Another object of the present invention is to provide a pharmaceutical product comprising such an antibody. Another object of the present invention is to provide a method for treating tumors using the antibody or the pharmaceutical product, for example. The present invention provides a CD147-specific antibody that activates CD147 and exhibits high antitumor efficacy. The present invention provides the anti-CD147 antibody that exhibits high antitumor efficacy independent of effector functions. The present invention provides a pharmaceutical composition comprising such an anti-CD147 antibody. The present invention provides a method for treating tumors using such an anti-CD147 antibody and/or pharmaceutical composition.
    Type: Grant
    Filed: October 12, 2021
    Date of Patent: October 4, 2022
    Assignee: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Keisuke Fukuchi, Kayoko Nanai, Masato Amano, Kozo Yoneda, Yusuke Totoki, Shoji Yamamoto
  • Publication number: 20220294210
    Abstract: A surge suppression device includes a plurality of series circuits each of which is composed of a resistor and a capacitor, a case in which a plurality of the resistors and a plurality of the capacitors are placed, wherein respective ends of the plurality of series circuits on the capacitor side are electrically connected to each other via a connection electrode provided on the case. A motor wiring component includes a plurality of conductive wires connected to stator coils of the motor, wiring terminals that are provided at ends of the plurality of conductive wires on a side opposite to the side connected to the stator coils and are connected to electrodes of a terminal block, and the surge suppression device.
    Type: Application
    Filed: February 22, 2022
    Publication date: September 15, 2022
    Inventor: Keisuke FUKUCHI
  • Publication number: 20220278592
    Abstract: A physical quantity detection device is provided with first and second retainers arranged to sandwich a wire, and a physical quantity sensor fixed to the wire by the first and second retainers. The physical quantity of the wire is detected by the physical quantity sensor, and the first and second retainers are fixed to the wire by being locked with each other.
    Type: Application
    Filed: February 22, 2022
    Publication date: September 1, 2022
    Inventor: Keisuke FUKUCHI
  • Publication number: 20220231467
    Abstract: A wiring component with temperature sensor includes an electric wire, a temperature sensor including a detection unit configured to detect temperature of the electric wire and a plurality of lead wires, and a plurality of connector pins respectively connected to the plurality of lead wires. The electric wire, the temperature sensor and the plurality of connector pins are collectively held by a holder made of a resin. The holder includes a connector housing member configured to hold the plurality of connector pins and a molded resin member covering a portion of the connector housing member.
    Type: Application
    Filed: December 16, 2021
    Publication date: July 21, 2022
    Inventors: Keisuke FUKUCHI, Junjie SHEN
  • Publication number: 20220221361
    Abstract: A physical quantity sensor-fixing structure includes a holder holding a physical quantity sensor including a detection unit to detect a physical quantity and a plurality of lead wires connected to the detection unit. The holder fixes the physical quantity sensor to a plurality of conductive support members to be respectively connected to the plurality of lead wires. The holder includes a main body member including a housing portion to house at least a portion of the physical quantity sensor, and a lid member covering at least a portion of the housing portion.
    Type: Application
    Filed: December 22, 2021
    Publication date: July 14, 2022
    Inventor: Keisuke FUKUCHI
  • Publication number: 20220106393
    Abstract: An object of the present invention is to provide a novel anti-CD147 antibody exhibiting potent antitumor efficacy and having excellent safety. Another object of the present invention is to provide a pharmaceutical product comprising such an antibody. Another object of the present invention is to provide a method for treating tumors using the antibody or the pharmaceutical product, for example. The present invention provides a CD147-specific antibody that activates CD147 and exhibits high antitumor efficacy. The present invention provides the anti-CD147 antibody that exhibits high antitumor efficacy independent of effector functions. The present invention provides a pharmaceutical composition comprising such an anti-CD147 antibody. The present invention provides a method for treating tumors using such an anti-CD147 antibody and/or pharmaceutical composition.
    Type: Application
    Filed: October 12, 2021
    Publication date: April 7, 2022
    Applicant: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Keisuke FUKUCHI, Kayoko NANAI, Masato AMANO, Kozo YONEDA, Yusuke TOTOKI, Shoji YAMAMOTO
  • Publication number: 20220045570
    Abstract: A motor wiring member configured to supply three-phase alternating current to a motor includes conductive wires, each of which has a connecting portion being provided at one end and being configured to be connected to a coil end of a stator of the motor, a terminal being provided at an other end of each conductive wire and being configured to be connected to an electrode of a terminal block, and a surge suppression section being configured to suppress an overvoltage from being applied to the motor. The surge suppression section includes three series circuits, each of which includes a resistor and a capacitor. One ends of the three series circuits are electrically connected to the conductive wires of respective phases, and other ends of the three series circuits are electrically connected to each other. The surge suppression section is provided along with the conductor wires near the terminal and is located between the terminal and the connecting portion.
    Type: Application
    Filed: August 4, 2021
    Publication date: February 10, 2022
    Inventors: Masanori SAGAWA, Yuta SUGIYAMA, Keisuke FUKUCHI, Yukio IKEDA
  • Patent number: 10995143
    Abstract: The present invention relates to the medical use of antibodies against the FGF receptor 4 (FGFR4) combined with Sorafenib, in particular for the prevention or treatment of hyperproliferative diseases associated with FGFR expression, overexpression or hyperactivity.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: May 4, 2021
    Assignees: Daiichi Sankyo Europe GmbH, Daiichi Sankyo Company Limited
    Inventors: Reimar Abraham, Keisuke Fukuchi
  • Publication number: 20210123811
    Abstract: A temperature sensor detects temperatures of at least two distribution lines and includes a temperature detection unit and a protection member that covers the temperature detection unit. The protection member is provided with a first abutting surface that has a concave shape corresponding to an outer shape of a first distribution line and is in contact with the first distribution line and a second abutting surface that has a concave shape corresponding to an outer shape of a second distribution line and is in contact with the second distribution line.
    Type: Application
    Filed: October 22, 2020
    Publication date: April 29, 2021
    Inventors: Keisuke Fukuchi, Masanori Sagawa, Masashi Yokoi
  • Publication number: 20200362033
    Abstract: An object of the present invention is to provide a novel anti-CD147 antibody exhibiting potent antitumor efficacy and having excellent safety. Another object of the present invention is to provide a pharmaceutical product comprising such an antibody. Another object of the present invention is to provide a method for treating tumors using the antibody or the pharmaceutical product, for example. The present invention provides a CD147-specific antibody that activates CD147 and exhibits high antitumor efficacy. The present invention provides the anti-CD147 antibody that exhibits high antitumor efficacy independent of effector functions. The present invention provides a pharmaceutical composition comprising such an anti-CD147 antibody. The present invention provides a method for treating tumors using such an anti-CD147 antibody and/or pharmaceutical composition.
    Type: Application
    Filed: July 26, 2018
    Publication date: November 19, 2020
    Applicant: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Keisuke FUKUCHI, Kayoko NANAI, Masato AMANO, Kozo YONEDA, Yusuke TOTOKI, Shoji YAMAMOTO
  • Patent number: 10358498
    Abstract: The present invention relates to novel antibodies against the FGF receptor 4 (FGFR4) and to the medical use thereof, in particular for the diagnosis prevention or treatment of diseases associated with FGFR expression, over expression or hyperactivity.
    Type: Grant
    Filed: August 11, 2015
    Date of Patent: July 23, 2019
    Assignees: Daiichi Sankyo Europe GmbH, Daiichi Sankyo Company, Limited
    Inventors: Reimar Abraham, Keisuke Fukuchi, Tanja Lange, Johannes Bange, Ichiro Watanabe, Shinko Hayashi, Toshiaki Ohtsuka